GlassScriptPhysician profile
Jocelyn Lambuth
NPI 1063948768
$1,519.65
in general payments reported to CMS, 2019-2025
16 companies · $333 in 2025
The $333 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $106 · 2021: $247 · 2022: $258 · 2023: $289 · 2024: $286 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $566.39 | 2021-2025 | Azstarys |
| Sobi, INC | $265.40 | 2021-2023 | |
| Cranial Technologies, INC | $218.75 | 2021-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $100.10 | 2020-2024 | M-M-R II, Gardasil 9, Vaxelis |
| Collegium Pharmaceutical, INC. | $84.25 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $66.15 | 2022-2024 | |
| Pfizer INC. | $41.90 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.96 | 2020-2021 | |
| Phadia US INC. | $21.46 | 2024 | Immunocap |
| Acadia Pharmaceuticals INC | $20.88 | 2025 | Daybue |
| Sanofi-Aventis U.S. LLC | $18.99 | 2023 | |
| Kyowa Kirin, INC. | $18.48 | 2025 | |
| Kaleo, INC. | $17.28 | 2024 | Auvi-Q |
| Supernus Pharmaceuticals, INC. | $16.68 | 2023 | Qelbree |
| Glaxosmithkline, LLC. | $16.23 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $13.75 | 2025 | Alvesco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jocelyn Lambuth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.